The RSI Oscillator for IDYA moved into overbought territory on November 17, 2026. Be on the watch for a price drop or consolidation in the future -- when this happens, think about selling the stock or exploring put options.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
Following a +4.50% 3-day Advance, the price is estimated to grow further. Considering data from situations where IDYA advanced for three days, in 217 of 288 cases, the price rose further within the following month. The odds of a continued upward trend are 75%.
IDYA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on October 29, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on IDYA as a result. In 88 of 107 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 82%.
The Moving Average Convergence Divergence Histogram (MACD) for IDYA turned negative on November 17, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In 33 of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at 69%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IDYA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 76%.
The Aroon Indicator for IDYA entered a downward trend on November 16, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 11 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.514) is normal, around the industry mean (3.592). P/E Ratio (-16.271) is within average values for comparable stocks, (-1.190). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (131.305) among similar stocks. P/S Ratio (14.409) is also within normal values, averaging (442.120).
The Tickeron PE Growth Rating for this company is 31 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 61 (best 1 - 100 worst), indicating steady price growth. IDYA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 89 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IDYA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.
The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
PYPD's Aroon Indicator triggered a bullish signal on November 17, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 115 similar instances where the Aroon Indicator showed a similar pattern. In 103 of the 115 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 90%.
The Momentum Indicator moved above the 0 level on October 20, 2026. You may want to consider a long position or call options on PYPD as a result. In 113 of 128 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 88%.
The Moving Average Convergence Divergence (MACD) for PYPD just turned positive on October 22, 2026. Looking at past instances where PYPD's MACD turned positive, the stock continued to rise in 44 of 50 cases over the following month. The odds of a continued upward trend are 88%.
PYPD moved above its 50-day moving average on October 22, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for PYPD crossed bullishly above the 50-day moving average on October 28, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 14 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 88%.
Following a +5.77% 3-day Advance, the price is estimated to grow further. Considering data from situations where PYPD advanced for three days, in 179 of 218 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
The 10-day RSI Indicator for PYPD moved out of overbought territory on November 12, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 18 similar instances where the indicator moved out of overbought territory. In 16 of the 18 cases, the stock moved lower in the following days. This puts the odds of a move lower at 89%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 41 of 49 cases where PYPD's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 84%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PYPD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.
PYPD broke above its upper Bollinger Band on November 11, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Price Growth Rating for this company is 35 (best 1 - 100 worst), indicating steady price growth. PYPD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 73 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 86 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (23.147) is normal, around the industry mean (3.592). P/E Ratio (-4.687) is within average values for comparable stocks, (-1.190). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (131.305) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (442.120).
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PYPD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
IDYA | PYPD | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 15 | 30 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 11 Undervalued | 86 Overvalued | |
PROFIT vs RISK RATING 1..100 | 89 | 100 | |
SMR RATING 1..100 | 94 | 100 | |
PRICE GROWTH RATING 1..100 | 61 | 35 | |
P/E GROWTH RATING 1..100 | 31 | 73 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
IDYA's Valuation (11) in the null industry is significantly better than the same rating for PYPD (86). This means that IDYA’s stock grew significantly faster than PYPD’s over the last 12 months.
IDYA's Profit vs Risk Rating (89) in the null industry is in the same range as PYPD (100). This means that IDYA’s stock grew similarly to PYPD’s over the last 12 months.
IDYA's SMR Rating (94) in the null industry is in the same range as PYPD (100). This means that IDYA’s stock grew similarly to PYPD’s over the last 12 months.
PYPD's Price Growth Rating (35) in the null industry is in the same range as IDYA (61). This means that PYPD’s stock grew similarly to IDYA’s over the last 12 months.
IDYA's P/E Growth Rating (31) in the null industry is somewhat better than the same rating for PYPD (73). This means that IDYA’s stock grew somewhat faster than PYPD’s over the last 12 months.
| IDYA | PYPD | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 86% | 2 days ago 89% |
| Stochastic ODDS (%) | 2 days ago 84% | 2 days ago 84% |
| Momentum ODDS (%) | 2 days ago 82% | 2 days ago 88% |
| MACD ODDS (%) | 2 days ago 69% | 2 days ago 88% |
| TrendWeek ODDS (%) | 2 days ago 78% | 2 days ago 80% |
| TrendMonth ODDS (%) | 2 days ago 85% | 2 days ago 83% |
| Advances ODDS (%) | 10 days ago 75% | 8 days ago 82% |
| Declines ODDS (%) | 2 days ago 76% | 3 days ago 84% |
| BollingerBands ODDS (%) | 2 days ago 76% | 2 days ago 88% |
| Aroon ODDS (%) | 2 days ago 83% | 2 days ago 90% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
IDYA’s FA Score shows that 2 FA rating(s) are green while PYPD’s FA Score has 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
IDYA’s TA Score shows that 4 TA indicator(s) are bullish while PYPD’s TA Score has 6 bullish TA indicator(s).
IDYA (@Biotechnology) experienced а -13.70% price change this week, while PYPD (@Biotechnology) price change was +3.65% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was -11.10%. For the same industry, the average monthly price growth was -10.38%, and the average quarterly price growth was -24.10%.
IDYA is expected to report earnings on Feb 23, 2027.
PYPD is expected to report earnings on Feb 10, 2027.
Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
A.I.dvisor indicates that over the last year, IDYA has been loosely correlated with RNA. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if IDYA jumps, then RNA could also see price increases.
| Ticker / NAME | Correlation To IDYA | 1D Price Change % | ||
|---|---|---|---|---|
| IDYA | 100% | -9.75% | ||
| RNA - IDYA | 48% Loosely correlated | +0.78% | ||
| SLDB - IDYA | 47% Loosely correlated | -3.86% | ||
| EDIT - IDYA | 46% Loosely correlated | -2.41% | ||
| RXRX - IDYA | 45% Loosely correlated | -6.37% | ||
| MGTX - IDYA | 44% Loosely correlated | -3.20% | ||
More | ||||
A.I.dvisor tells us that PYPD and BCYC have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PYPD and BCYC's prices will move in lockstep.
| Ticker / NAME | Correlation To PYPD | 1D Price Change % | ||
|---|---|---|---|---|
| PYPD | 100% | +6.34% | ||
| BCYC - PYPD | 31% Poorly correlated | +0.63% | ||
| TSHA - PYPD | 31% Poorly correlated | -1.48% | ||
| IDYA - PYPD | 29% Poorly correlated | -9.75% | ||
| AMLX - PYPD | 29% Poorly correlated | -1.01% | ||
| SYRE - PYPD | 29% Poorly correlated | -5.60% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| TSEG | 2.12 | 0.09 | +4.43% |
| Leverage Shares 2X Long TSEM Daily ETF (TSEG) | |||
| DDFD | 20.19 | -0.12 | -0.61% |
| Innovator Equity Dual Directional 15 Buffer ETF - December (DDFD) | |||
| FAUG | 56.01 | -0.46 | -0.81% |
| FT Vest U.S. Equity Buffer ETF - August (FAUG) | |||
| KBWD | 9.99 | -0.23 | -2.25% |
| Invesco KBW High Dividend Yield Financial ETF (KBWD) | |||
| RMRC | 25.56 | -0.62 | -2.38% |
| ARMOR Core Risk-Managed ETF (RMRC) | |||